Up a level |
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Docobo-Perez, Fernando, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Gastine, Silke, Dona, Ruwanthi Kolamunnage, de Costa, Renata MA et al (show 8 more authors)
(2021)
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Antimicrobial Agents and Chemotherapy, 65 (7).
e0029321-.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, McEntee, Laura, Johnson, Adam, Farrington, Nicola, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Jagota, Bhavana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally et al (show 6 more authors)
(2022)
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (12).
pp. 3349-3357.
Nichols, Wright W, Newell, Paul, Critchley, Ian A, Riccobene, Todd and Das, Shampa ORCID: 0000-0002-2540-4816
(2018)
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62 (6).
e02446-e02417.
Das, Shampa ORCID: 0000-0002-2540-4816, Li, Jianguo, Iaconis, Joseph, Zhou, Diansong, Stone, Gregory G, Yan, Jean Li and Melnick, David
(2019)
Ceftaroline fosamil doses and b breakpoints for <i>Staphylococcus aureus</i> in complicated skin and soft tissue infections.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (2).
pp. 425-431.
Corey, G Ralph, Wilcox, Mark H, Gonzalez, Jesus, Jandourek, Alena, Wilson, David J, Friedland, H David, Das, Shampa ORCID: 0000-0002-2540-4816, Iaconis, Joseph and Dryden, Matthew
(2019)
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 53 (6).
pp. 830-837.
Li, Jianguo, Lovern, Mark, Green, Michelle L, Chiu, Joannellyn, Zhou, Diansong, Comisar, Craig, Xiong, Yuan, Hing, Jeremy, MacPherson, Merran, Wright, James G et al (show 3 more authors)
(2019)
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 12 (2).
pp. 151-163.
Nichols, Wright W, Stone, Gregory G, Newell, Paul, Broadhurst, Helen, Wardman, Angela, MacPherson, Merran, Yates, Katrina, Riccobene, Todd, Critchley, Ian A and Das, Shampa ORCID: 0000-0002-2540-4816
(2018)
Ceftazidime-Avibactam Susceptibility Breakpoints Against Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy, 62 (11).
e02590-e02517.
Cristinacce, Andrew, Wright, James G, Macpherson, Merran, Iaconis, Joseph and Das, Shampa ORCID: 0000-0002-2540-4816
(2021)
Comparing probability of target attainment against <i>Staphylococcus aureus</i> for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 99 (4).
115292-.
Das, Shampa ORCID: 0000-0002-2540-4816, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J, Newell, Paul, Melnick, David, Critchley, Ian A, Stone, Gregory G and Nichols, Wright W
(2019)
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (4).
e02187-e02118.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally, Franceschi, Francois et al (show 5 more authors)
(2022)
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (5).
pp. 1334-1343.
Das, Shampa ORCID: 0000-0002-2540-4816, Fitzgerald, Richard, Ullah, Asad, Bula, Marcin, Collins, Andrea M, Mitsi, Elena, Reine, Jesus, Hill, Helen, Rylance, Jamie, Ferreira, Daniela M et al (show 10 more authors)
(2021)
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 65 (1).
e01468-e01420.
Farrington, Nicola ORCID: 0000-0003-2300-9430, Dubey, Vineet, Johnson, Adam, Horner, Iona, Stevenson, Adam, Unsworth, Jennifer, Jimenez-Valverde, Ana ORCID: 0000-0003-4284-5629, Schwartz, Julie, Das, Shampa ORCID: 0000-0002-2540-4816, Hope, William ORCID: 0000-0001-6187-878X et al (show 1 more authors)
(2024)
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.
mBio, 15 (2).
e0316523-.
McEntee, Laura, Johnson, Adam ORCID: 0000-0002-6684-3321, Farrington, Nicola, Unsworth, Jennifer, Dane, Aaron, Jain, Akash, Cotroneo, Nicole, Critchley, Ian, Melnick, David, Parr, Thomas et al (show 3 more authors)
(2019)
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (8).
e00603-e00619.
McEntee, Laura
(2023)
Pharmacokinetics & Pharmacodynamics of New Treatment Options for Infections caused by Multi-Drug Resistant Gram-Negative Pathogens.
PhD thesis, University of Liverpool.
Li, Jianguo, Das, Shampa ORCID: 0000-0002-2540-4816, Zhou, Diansong and Al-Huniti, Nidal
(2019)
Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community-Acquired Pneumonia Treated With Ceftaroline Fosamil.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 8 (5).
pp. 682-694.
Dimelow, Richard, Wright, James G, MacPherson, Merran, Newell, Paul and Das, Shampa ORCID: 0000-0002-2540-4816
(2018)
Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers.
DRUGS IN R&D, 18 (3).
pp. 221-230.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, da Costa, Renata MA, Ellis, Sally, Franceschi, Francois, Sharland, Mike, Piddock, Laura, Das, Shampa ORCID: 0000-0002-2540-4816 and Hope, William ORCID: 0000-0001-6187-878X
(2021)
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
PEDIATRIC DRUGS, 23 (5).
pp. 465-484.
Das, Shampa ORCID: 0000-0002-2540-4816, Zhou, Diansong, Nichols, Wright W, Townsend, Andy, Newell, Paul and Li, Jianguo
(2020)
Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumonia.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 76 (3).
pp. 349-361.